The role of hypoxia on the acquisition of epithelialmesenchymal transition and cancer stemness: a possible link to epigenetic regulation

키워드

참고문헌 (79)

1. Foster JG, "The hypoxic tumor microenvironment:driving the tumorigenesis of non-smallcell lung cancer", Future Oncol, 10, pp.2659~2674 (2014)
2. Hockel M, "Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects", J Natl Cancer Inst, 93, pp.266~276 (2001)
3. Gao T, "The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment", Biomed Pharmacother, 80, pp.393~405 (2016)
4. Li M, "Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells", Oncol Rep, 36, pp.521~527 (2016)
5. Ye LY, "Hypoxia-induced epithelialto-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis", Cancer Res, 76, pp.818~830 (2016)
6. Thiery JP, "Epithelialmesenchymal transitions in development and disease", Cell, 139, pp.871~890 (2009)
7. Li L, "Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation", Pharmacol Ther, 150, pp.33~46 (2015)
8. Garg M., "Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer", Expert Opin Ther Targets, 19, pp.285~297 (2015)
9. Reya T, "Stem cells, cancer, and cancer stem cells", Nature, 414, pp.105~111 (2001)
10. Medema JP., "Cancer stem cells: the challenges ahead", Nat Cell Biol, 15, pp.338~344 (2013)
11. Mimeault M, "Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells", J Cell Mol Med, 17, pp.30~54 (2013)
12. Shukla S, "Epigenetics of cancer stem cells:pathways and therapeutics", Biochim Biophys Acta, 1840, pp.3494~3502 (2014)
13. Jones PA., "Functions of DNA methylation: islands, start sites, gene bodies and beyond", Nat Rev Genet, 13, pp.484~492 (2012)
14. Vaupel P, "Detection and characterization of tumor hypoxia using pO2 histography", Antioxid Redox Signal, 9, pp.1221~1235 (2007)
15. Bertout JA, "The impact of O2 availability on human cancer", Nat Rev Cancer, 8, pp.967~975 (2008)
16. Myszczyszyn A, "The role of hypoxia and cancer stem cells in renal cell carcinoma pathogenesis", Stem Cell Rev, 11, pp.919~943 (2015)
17. Yeh KA, "Polarographic needle electrode measurements of oxygen in rat prostate carcinomas:accuracy and reproducibility", Int J Radiat Oncol Biol Phys, 33, pp.111~118 (1995)
18. Vaupel P, "Hypoxia in cancer: significance and impact on clinical outcome", Cancer Metastasis Rev, 26, pp.225~239 (2007)
19. Koch CJ, "Optimizing hypoxia detection and treatment strategies", Semin Nucl Med, 45, pp.163~176 (2015)
20. Shimoda LA, "HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease", Am J Respir Crit Care Med, 183, pp.152~156 (2011)
21. Sharp FR, "HIF1 and oxygen sensing in the brain", Nat Rev Neurosci, 5, pp.437~448 (2004)
22. Harris AL., "Hypoxia: a key regulatory factor in tumour growth", Nat Rev Cancer, 2, pp.38~47 (2002)
23. Gordan JD, "Hypoxia-inducible factors: central regulators of the tumor phenotype", Curr Opin Genet Dev, 17, pp.71~77 (2007)
24. Zhao J, "The emerging role of hypoxia-inducible factor-2 involved in chemo", radioresistance in solid tumors, 2015, pp.41, 623~633
25. Zhang J, "Signal transduction pathways of EMT induced by TGF-beta, SHH, and WNT and their crosstalks", J Clin Med, 5, pp.41~ (2016)[DOI]
26. Jiang J, "EMT: a new vision of hypoxia promoting cancer progression", Cancer Biol Ther, 11, pp.714~723 (2011)
27. Imai T, "Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells", Am J Pathol, 163, pp.1437~1447 (2003)
28. Hung JJ, "Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable nonsmall cell lung cancer", Thorax, 64, pp.1082~1089 (2009)
29. Nishi H, "Hypoxia-inducible factor-1 transactivates transforming growth factorbeta3in trophoblast", Endocrinology, 145, pp.4113~4118 (2004)
30. Sebastian Diecke, "Recent technological updates and clinical applications of induced pluripotent stem cells", The Korean Journal of Internal Medicine, 29(5), pp.547~557 (2014), 대한내과학회[DOI]
31. 김나연, "Clinical applications of mesenchymal stem cells", The Korean Journal of Internal Medicine, 28(4), pp.387~402 (2013), 대한내과학회[DOI]
32. Clarke MF, "Cancer stem cells:perspectives on current status and future directions:AACR Workshop on cancer stem cells", Cancer Res, 66, pp.9339~9344 (2006)
33. Hamburger AW, "Primary bioassay of human tumor stem cells", Science, 197, pp.461~463 (1977)
34. Sourisseau T, "Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough?", J Thorac Oncol, 9, pp.7~17 (2014)
35. Giangreco A, "Stem cells are dispensable for lung homeostasis but restore airways after injury", Proc Natl Acad Sci U S A, 106, pp.9286~9291 (2009)
36. Akunuru S, "Non-small cell lung cancer stem", progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity, 2012, pp.3, e352~
37. Yang CH, "Identification of CD24as a cancer stem cell marker in human nasopharyngeal carcinoma", PLoS One, 9, pp.e99412~ (2014)
38. Li Z, "Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells", Cancer Cell, 15, pp.501~513 (2009)
39. McCord AM, "Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro", Mol Cancer Res, 7, pp.489~497 (2009)
40. Koukourakis MI, "Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer", Int J Radiat Biol, 92, pp.353~363 (2016)
41. Seidel S, "A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha", Brain, 133, pp.983~995 (2010)
42. Wang Z, "Oncogenic roles and drug target of CXCR4", CXCL12 axis in lung cancer and cancer stem cell, 2016, pp.37, 8515~8528
43. 조병식, "Targeting the CXCL12", CXCR4 axis in acute myeloid leukemia: from bench to bedside, 2017, pp.32(2), 248~257[DOI]
44. Nian WQ, "CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics", Mol Cell Biochem, 355, pp.241~248 (2011)
45. Romain B, "Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer", Mol Cancer, 13, pp.58~ (2014)
46. Liang Z, "CXCR4", CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway, 2007, pp.359, 716~722
47. Isabel Fabregat, "New Insights into the Crossroads between EMT and Stemness in the Context of Cancer", Journal of Clinical Medicine, 5(3), pp.37~ (2016), MDPI AG[DOI]
48. Mani SA, "The epithelial-mesenchymal transition generates cells with properties of stem cells", Cell, 133, pp.704~715 (2008)
49. Morel AP, "Generation of breast cancer stem cells through epithelial-mesenchymal transition", PLoS One, 3, pp.e2888~ (2008)
50. Rhim AD, "EMT and dissemination precede pancreatic tumor formation", Cell, 148, pp.349~361 (2012)
51. Kurrey NK, "Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells", Stem Cells, 27, pp.2059~2068 (2009)
52. Wellner U, "The EMT-activator ZEB1 promotes tumorigenicity by repressing stemnessinhibiting microRNAs", Nat Cell Biol, 11, pp.1487~1495 (2009)
53. Mima K, "CD44s regulates the TGF-beta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma", Cancer Res, 72, pp.3414~3423 (2012)
54. Nomura A, "CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer", Oncotarget, 6, pp.8313~8322 (2015)
55. Huangyang P, "Epigenetic regulation of epithelial to mesenchymal transition", Curr Cancer Drug Targets, 13, pp.973~985 (2013)
56. Hennessy BT, "Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics", Cancer Res, 69, pp.4116~4124 (2009)
57. Chen Y, "DNA methylation is associated with transcription of snail and slug genes", Biochem Biophys Res Commun, 430, pp.1083~1090 (2013)
58. Deneberg S, "Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks", Blood, 118, pp.5573~5582 (2011)
59. Chang CJ, "p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs", Nat Cell Biol, 13, pp.317~323 (2011)
60. Taube JH, "Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties", Sci Rep, 3, pp.2687~ (2013)
61. Simonsson S, "DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei", Nat Cell Biol, 6, pp.984~990 (2004)
62. El Helou R, "Brief reports: a distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome", Stem Cells, 32, pp.3031~3036 (2014)
63. Yamazaki Y, "Gradual DNA demethylation of the Oct4promoter in cloned mouse embryos", Mol Reprod Dev, 73(1), pp.180~188 (2006)
64. Liu CC, "IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation", Int J Cancer, 136, pp.547~559 (2015)
65. Suzuki M, "Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis", Int J Oncol, 33, pp.113~119 (2008)
66. Zhi Y, "Down-regulation of CXCL12 by DNA hypermethylation and its involvement in gastric cancer metastatic progression", Dig Dis Sci, 57, pp.650~659 (2012)
67. Fridrichova I, "CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers", Transl Res, 165, pp.717~730 (2015)
68. Kubarek L, "Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells", FEBS Lett, 581, pp.1441~1448 (2007)
69. Przybylski M, "Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B", Biomed Pharmacother, 64, pp.254~258 (2010)
70. Koga C, "Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells", Ann Surg Oncol, 21(Suppl 4), pp.S591~S600 (2014)
71. Liu C, "The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44", Nat Med, 17, pp.211~215 (2011)
72. Shimono Y, "Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells", Cell, 138, pp.592~603 (2009)
73. Gwak JM, "MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer", Breast Cancer Res Treat, 147, pp.39~49 (2014)
74. Yu T, "MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt", beta-catenin signaling pathway, 2014, pp.33, 5017~5027
75. Yin P, "MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells", Mol Biotechnol, 57, pp.1~11 (2015)
76. Sarvi S, "CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist", Cancer Res, 74, pp.1554~1565 (2014)
77. Chen Q, "Promoter methylation regulates cadherin switching in squamous cell carcinoma", Biochem Biophys Res Commun, 315, pp.850~856 (2004)
78. Peter ME., "Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression", Cell Cycle, 8, pp.843~852 (2009)
79. Chen Y, "CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice", Hepatology, 61, pp.1591~1602 (2015)

관련 논문AI추천